Key result
Valsartan and fluvastatin are under investigation as upstream therapies for non-permanent AF in hypertensive patients.
Answers are grounded in this paper and cite their sources.
Ethical bodies that approved the study.
No takes yet. Share an insight, caveat, or question.
Qi et al. (2015) studied this question. Valsartan and fluvastatin are being investigated as upstream therapies for hypertensive patients with non-permanent atrial fibrillation in the VF-HT-AF randomized controlled trial protocol.
Synapse has enriched 10 related papers. Consider them for comparative context: